IDXX - IDEXX Laboratories Non-GAAP EPS of $1.58 misses by $0.05 revenue of $860.55M misses by $1.57M
- IDEXX Laboratories press release ( NASDAQ: IDXX ): Q2 Non-GAAP EPS of $1.58 misses by $0.05 .
- Revenue of $860.55M (+4.2% Y/Y) misses by $1.57M .
- FY2022 Outlook : Revenue in the range of $3.305B to $3.385B vs. consensus of $3.41B; operating margins of 26.4% to 26.9%; EPS outlook of $7.77 - $8.05 reflects an adjustment of $0.32 at midpoint, including $0.05 of negative impact from higher projected interest rates and $0.03 of negative impact related to the strengthening U.S. dollar vs. consensus of $8.24.
For further details see:
IDEXX Laboratories Non-GAAP EPS of $1.58 misses by $0.05, revenue of $860.55M misses by $1.57M